Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0RDB stock hub

LON/0RDB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0RDBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

182.5M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0RDB

In the news

Latest news · LON/0RDB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-2.5

P25 -54.2P50 2.1P75 13.7

ROIC-5.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0RDB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

174

Groups with data

Currency

EUR

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Spain
Country code	UK
Employees	46
Employees Change	1%
Employees Change Percent	2.17
Enterprise value	EUR 173.4M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	ES0167733015
Last refreshed	2026-05-10
Market cap	EUR 182.5M
Price	EUR 2.73
Price currency	EUR
Rev Per Employee	207,367.63x
Sector	Healthcare
Sic	2836
Symbol	lon/0RDB
Website	https://www.oryzon.com/en

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.25%
EV Earnings	-76.27x
EV/FCF	-82.27x
EV/Sales	18.35x
FCF yield	-1.15%
P/B ratio	1.78x
P/S ratio	19.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-52.25%
EBITDA Margin	-51.19%
Gross margin	97.42%
Gross Profit	EUR 9.3M
Gross Profit Growth	50.95%
Gross Profit Growth Q	50.95%
Gross Profit Growth3 Y	-11.24%
Gross Profit Growth5 Y	3.44%
Net Income	EUR -2.3M
Net Income Growth Years	1%
Pretax Margin	-51.2%
Profit Margin	-23.83%
Profit Per Employee	EUR -49,412
ROA	-2.81
Roa5y	-3.24
ROCE	-4.44
ROE	-2.53
Roe5y	-4.67
ROIC	-5.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	1.41%
Cagr3y	8.17%
Cagr5y	-4.42%
EPS Growth Years	4
Revenue Growth	48.59x
Revenue Growth Q	48.59x
Revenue Growth Years	0x
Revenue Growth3 Y	-11.36x
Revenue Growth5 Y	2.81x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.09
Assets	EUR 126.1M
Cash	EUR 24.7M
Current Assets	EUR 26.5M
Current Liabilities	EUR 13.6M
Debt	EUR 15.5M
Debt Equity	EUR 0.15
Debt FCF	EUR -7.35
Equity	EUR 102.8M
Interest Coverage	-9,403.6
Liabilities	EUR 23.3M
Long Term Assets	EUR 99.6M
Long Term Liabilities	EUR 9.6M
Net Cash	EUR 9.3M
Net Cash By Market Cap	EUR 5.07
Net Debt Equity	EUR -0.09
Tangible Book Value	EUR 102.6M
Tangible Book Value Per Share	EUR 1.32
WACC	6.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.95
Inventory Turnover	84.23
Net Working Capital	EUR -2.1M
Quick ratio	1.94
Working Capital	EUR 13M
Working Capital Turnover	EUR 1.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-19.72%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	1.41%
200-day SMA	3.02
3Y total return	26.59%
50-day SMA	2.85
50-day SMA vs 200-day SMA	50under200
5Y total return	-20.23%
All Time High	5.07
All Time High Change	-46.17%
All Time High Date	2018-07-04
All Time Low	1.4
All Time Low Change	94.58%
All Time Low Date	2024-12-31
ATR	0.05
Beta	0.44
Ch YTD	-12
High	2.77
High52	4
High52 Date	2025-10-13
High52ch	-31.8%
Low	2.73
Low52	2.57
Low52 Date	2025-08-08
Low52ch	6.15%
Ma50ch	-4.25%
Price vs 200-day SMA	-9.67%
RSI	41.02
RSI Monthly	51.57
RSI Weekly	41.87
Sharpe ratio	0.16x
Sortino ratio	0.38
Total Return	-19.72%
Tr YTD	-12
Tr1m	-0.87%
Tr1w	-1.16%
Tr3m	-13.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -5M
Operating Income Growth Q	9.85
Operating margin	-52.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	60,520,924%
Net Borrowing	2,700,635.8
Shares Insiders	13.92%
Shares Institutions	0.9%
Shares Qo Q	3.08%
Shares Yo Y	19.72%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -2.1M
Average Volume	1,026.1x
Bv Per Share	1.33
CAPEX	EUR -51,814
Ch1m	-0.87
Ch1w	-1.16
Ch1y	1.41
Ch3m	-13.26
Ch3y	26.59
Ch5y	-20.23
Ch6m	-16.96
Change	-2.5%
Change From Open	-1.52
Close	2.8
Days Gap	-1
Depreciation Amortization	100,468.2
Dollar Volume	68.2
Earnings Date	2026-05-15
EBIT	EUR -5M
EBITDA	EUR -4.9M
EPS	EUR -0.03
F Score	5
FCF	EUR -2.1M
FCF EV Yield	-1.22x
Financing CF	31,521,569
Fiscal Year End	December
Founded	2,000
Income Tax	EUR -2.6M
Investing CF	-9,628,660
Is Primary Listing	0
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Ma150	3.1
Ma150ch	-12.03%
Ma20	2.82
Ma20ch	-3.23%
Net CF	19,833,707
Next Earnings Date	2026-05-15
Open	2.77
Position In Range	0
Ppne	328,794.2
Price Date	2026-05-08
Ptbv Ratio	1.78
Relative Volume	0.02x
Revenue	9,538,911x
Tax By Revenue	-27.37x
Tr6m	-16.96%
Volume	25
Z Score	4.46

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0RDB pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0RDB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0RDB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.9%

Share of float held by funds and institutions

Insider ownership

+13.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+19.7%

Negative means the company is buying back shares.

Technical

LON/0RDB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.0

Neutral momentum band

Price vs 200-day MA

-9.7%

50/200-day relationship not available

Beta (5Y)

0.44

Less volatile than the market

Sharpe ratio

0.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0RDB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0RDB stock rating?

lon/0RDB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0RDB analysis?

The full report lives at /stocks/lon/0RDB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0RDB?

The latest report frames lon/0RDB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0RDB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.